References
- BASSAN, M.M. and ROGEL, S.: Current practice in the use of anticoagulant for ischemic heart disease. A survey of 200 hospitals. Heart and Lung, 5, 742, 1976.
- BERKMAN, M.: Le traitement anticoagulant au long cours. Ses indications et ses limites. Sem. Hop. Paris, 50, 2025, 1974.
- BJERKELUND, C.J.: Anticoagulant therapy in myocardial infarction. Heart and Lung, 4, 61, 1975.
- BORN, G.V.R. and CROSS, M.J.: The aggregation of blood platelets. J. Physiol., 168, 178, 1963.
- BOUSSER, M.G.: Les substances antiagriSgantcs plaquettaires. Rev. Prat., 23, 60, 1973.
- BOWIE, E.J.W., OWEN, C.A., THOMPSON, J.M. and DIDISHEIM, P.: A test of platelet adhesiveness. Mayo Clin. Proc., 44, 306, 1969.
- CHANDLER, A.B.: The platelet in thrombus formation. In: The platelet (BRINKHOUS, K.M., SHERMER, R.W. and MOSTOFI, F.K. Eds) p. 183. The Williams and Wilk ins Company. Baltimore 1971.
- COOPERATIVE CLINICAL TRIAL: Anticoagulants in acute myocardial infarction. JAMA, 225, 724. 1973.
- DE GAETANO, G.: Pharmacological properties of drugs inhibiting platelet aggregation. Acta clin. belg., 30, 184, 1975.
- DICK, W. MATIS, P. and MAYER, W.: Results of alternating anticoagulant prophylaxis in sugery. Thrombos. Diathes. haemorrh., 3, II, 1959.
- DOUGLAS, A.S.: Anticoagulant therapy. Oxford. Blackwell, 1962.
- DOUGLAS, A.S.: Management of thrombotic diseases. Semin. Hemat., 8, 95, 1971.
- EBERT, R.V., BORDEN, C.W., HIPP, H.R., HOLYMAN, D. LYON, A.F. and SCHNAPER, H.: Long term anticoagulant therapy after myocardial infarction. Final report of the Veterans Administration Cooperative Study. JAMA, 207, 2263, 1969.
- GALLUS, A.S. and HIRSH, J.: Prevention of venous thromboembolism. Semin. Thrombos. Hemost., 2, 232, 1976.
- GALLUS, A.S. and HIRSH, J.: Treatment of venous thromboembolic disease. Semin. Thrombos. Hemost., 2, 291, 1976.
- GENTON, E. and STEELE, P.: Platelets, drugs and heart disease. In « Platelets, drugs and thrombosis» (HIRSH, J., CADE, J.F. and GALLUS, A.S. Eds) p. 263. S. KARGER, Basel 1975.
- GENTON, E. GENT, M. HIRSH, J. and MARKER, L.A.: Platelet inhibiting drugs in the prevention of clinical thrombotic disease; part I. New Engl. J. Med., 293, 1174, 1975.
- GENTON, E., GENT, M., HIRSH, J. and HARKER, L.A.: Platelet inhibiting drugs in the prevention of clinical thrombotic disease; part II. New Engl. J. Med., 293, 1236, 1975.
- GENTON, E. GENT, M., HIRSH. J. and HARKER, L.A.: Platelet inhibiting drugs in the prevention of clinical thrombotic disease; part III. New Engl. J. Med., 293, 1236, 1975.
- HARKER, L.A. and SLICHTER, S.J.: Platelet and fibrinogen consumption in man. New Engl. J. Med., 287, 999, 1972.
- HARKER, L.A. and SLICHTER, S.J.: Arterial and venous thromboembolism: Kinetic, characterization and evaluation of therapy. Thrombos. Diathes. haemorrh., 31,188, 1974.
- HARKER, LX HIRSH, J., GENT, M. and GENTON, E.: Critical evaluation of platelet inhibiting drugs in thrombotic disease. In • Progress in Haematology » (BROWN, E.B. Eds) vol. 9, p. 229. Grune and Stratton N.Y. San Francisco and London, 1975.
- HARVALD, B. HILDEN, T. and LUND, E.: Long term anticoagulant therapy after myocardial infarction. Lancet, ii, 626, 1962.
- HEMKER, H.C., VELTKAMP, J.J. and LOELIGER, E.A.: Kinetic aspects of the interaction of blood clotting enzymes. Demonstration of an inhibitor prothrombin conversion in vitamin K deficiency. Thrombos. Diathes. haemorrh., 19, 346, 1968.
- HIRSH, J., GENT, M. and GENTON, E.: The current status of platelet suppressive drugs in the treatment of thrombosis. Thrombos. Diathes. haemorrh., 33, 406, 1975.
- HOLMSEN, H.: The platelet: Its membrane, physiology and biochemistry. Clin. Haemat., 1, 235, 1972.
- HUME, M. SEVITT, S. and THOMAS, D.F. ; Venous thrombosis and pulmonary embolism. Harvard University Press, Cambridge, Massachussetts, 1970.
- INTERNATIONAL ANTICOAGULANT REVIEW GROUP: Collaborative analysis of long term anticoagulant administration after acute myocardial infarction. Lancet, i 203 1970.
- JOHNSON, S.A.: Platelet and thrombosis interaction with components of the vessel weal. In «The platelet» (BRINKHOUS, K M., SHERMER, R.W. and MOSTOFI, F Eds) p. 198. The Williams and Wilkins Company—Baltimore 1971.
- LATOUR, J.G.: Antiagregants et prevention de la thrombose. Revue clinique. Dans: « l’agregation plaquettaire » (rapports presentes au XLe congres frangais de medecine-Dakar 1975) p. 127. Masson et Cic Eds Paris 1976.
- LOELIGER, E.A., HENSEN, A., KREES, F VAN DYK, L.M., FEKKE, N. DE JONGE, H. and HEMKER, H.C.: A double-blind trial of long term anticoagulant treatment after myocardial infarction. Acta med scand., 182, 49, 1967.
- 32. LOELIGER, E.A.: Progress in the control of oral anticoagulation. Thrombos. Diathes haemorrh., 28, 109, 1972.
- LOELIGER, E.A.: Anticoagulant induced haemorrhages. In « Blood disorders due to drugs and other agents ». (G1RWOOD R.h. Eds) p. 221. Exerpta Medica, Amsterdam 1973.
- MOSLEY, D.H., SCIIATZ, I.J., BRENEMAN, G.M. and KEYES, J.W.: Long term anticoagulant therapy. JAMA, 186, 128 (1963).
- MUSTARD, J.F.: Haemostasis and thrombosis. Semin. Hemat., 5, 91, 1968.
- MUSTARD, J.F. and PACKHAM, M.A.: Factors influencing platelet function: adhesion, release and aggregation. Pharmacology, 22 97, 1970.
- NUSSBAUM, M. and MOSCHOS, C.B.: An ticoagulant and anticoagulation. Med. Clin N. Amcr, 60, 855, 1976.
- PATRON, G. et DEGEORGES, M.: Accidents des substances anticoagulantes L»t thrombolytiques et leur traitemcnt. Rcv Prat., 23, 5467, 1973.
- RAYNAUD, F.H., GRIGNER, P., BRo. CHIER, M. ct RAYNAUD, R.: La place des medicaments librinolytiques et antiagregants plaquettaires en therapeutique. Ann Cardiol. Angeiol., 22, 461, 1973.
- SALZMAN, E.W., HARRIS, W.H. and DE SANCTIS, R.W.: Anticoagulation for prevention of thromboembolism following fracture of the hips. New Engl. J. Med., 275, 122, 1966.
- SEVITT, S. and GALLAGHER, N.G.: Prevention of venous thrombosis and pulmonary embolism in injured patients. Lancet, ii, 981, 1959.
- SEVITT, S. and GALLAGHER, N.G.: Venous thrombosis and pulmonary embolism. A clinicopathological study in injured and burned patients. Brit. J. Surg., 48, 475, 1961.
- THOMAS, D.P.: The platelet contribution to arterial and venous thrombosis. Clin. Hcmat., 1, 267, 1972.
- VERMYLEN, J.: Clinical pharmacology of antiaggrcgating substances. Acta clin. belg., 30, 204, 1975.
- VERSTRAETE, M.: Indications des anticoagulants et thrombolytiques dans la prevention et le traitement des thromboembolics. Sem. Hop. Paris, 51, 1507, 1975.
- VERSTRAETE, M.: Registry of prospective clinical trials. Second report. Thrombos. Haemost., 36, 239, 1976.
- VERSTRAETE, M.: Are agents affecting platelet functions clinically useful ? Amer. J. Med., 61, 897, 1976.
- WEISS, H.J.: Platelets and their role in haemostasis. Ann. N. Y. Acad. Sci., 201, 1, 1972.
- WEISS, H.J.: The pharmacology of platelet inhibition. In: Progress in Hemostasis and thrombosis. Vol. I, p. 199. (SPAET, TH. Eds) Grune and Stratton. New York, 1972.
- WEISS, II.J.: Antiplatelets drugs. A new parmacologic approach to the prevention of thrombosis. Amer. Heart. J., 92, 86, 1976.
- WORKING PARTY OF THE MEDICAL RESEARCH COUNCIL: An assessment of long term anticoagulant administration after cardiac infarction. Brit. Med. J., 2, 237, 1964.
- WRIGHT, I.S., MAPLE, CD. and BECK, D.F.: Report of the committee for the evaluation of anticoagulants in the treatment of coronary thrombosis with myocardial infarction. Amer. Heart. J., 36, 801, 1948.
- WRIGHT, I.S.: Recent developments in antithrombotic therapy perpective. Ann. int. Med., 71, 823, 1969.